RNTXRein Therapeutics Inc. Common Stock
0.8180USD+3.28%Mkt Cap: 70.57M $P/E: —3d ago
Rein Therapeutics Inc., a biopharmaceutical company, focuses on developing medicines to address unmet medical needs in orphan pulmonary and fibrosis indications in the United States. The company's lead product candidate …
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap70.57M $
Enterprise Value114.43M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-49.87M $
Revenue/Share—
Last Price0.8180 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees10
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-5.31
EV/Revenue—
P/S—
P/B-0.67
EPS (TTM)-1.67
EPS (Forward)—
52W Range
0.69408% of range2.180
52W High2.180 USD
52W Low0.6940 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE177.56%
ROA-206.44%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-19.36M $
CapEx (TTM)—
FCF Margin—
FCF Yield-11.48%
Net Debt478.00K $
Net Debt/EBITDA-0.02
Balance Sheet
Debt/Equity42.47
Current Ratio0.40
Quick Ratio0.33
Book Value/Sh-1.1920 USD
Cash/Share0.0520 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:20
Split DateNov 11, 2022
Analyst Consensus
Rating1.5 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)6.000 USD
Upside (mean)+633.5%
Target Range4.000 USD – 8.000 USD
$4.000+633.5% to mean$8.000
# Analysts2
Ownership
Shares Out.86.27M
Float64.62M
Insiders5.37%
Institutions53.22%
Short Interest
Short Ratio2.0d
Short % Float1.02%
Short % Out.1.02%
Shares Short875.04K
Short (prev mo.)898.10K
Technical
SMA 500.8766 (-6.7%)
SMA 2001.194 (-31.5%)
Beta1.37
S&P 52W Chg18.16%
Avg Vol (30d)393.20K
Avg Vol (10d)513.57K
Technical Indicators
RSI (14)48.7
MACD-0.0217
MACD Signal-0.0340
MACD Hist.+0.0123
BB Upper0.8468 USD
BB Middle0.7854 USD
BB Lower0.7241 USD
BB Width15.63%
ATR (14)0.0707 USD
Vol Ratio (20d)1.45x